RiverPark Advisors’s Aehr Test Systems AEHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$172K Buy
4,647
+1,249
+37% +$40K 0.06% 93
2025
Q4
$68.6K Buy
3,398
+1,987
+141% +$48.1K 0.02% 132
2025
Q3
$42.5K Buy
+1,411
New +$30.6K 0.02% 124
2024
Q2
Sell
-2,069
Closed -$25.7K 132
2024
Q1
$25.7K Buy
2,069
+1,620
+361% +$27K 0.02% 125
2023
Q4
$11.9K Buy
449
+83
+23% +$2.42K 0.01% 105
2023
Q3
$16.7K Buy
+366
New +$17K 0.02% 97

Other funds holding AEHR

RiverPark Advisors's AEHR Position: Q1 2026 in Review

RiverPark Advisors increased its Aehr Test Systems (AEHR) stake by 37% in Q1 2026, buying an estimated $40K and bringing the position to 4,647 shares worth $172K. The position accounts for 0.06% of the portfolio, ranked #93.

RiverPark Advisors first reported a position in AEHR in Q3 2023 and has held it in 6 quarters since. 191 funds tracked by Wall St. Rank hold AEHR as of Q1 2026.

  • RiverPark Advisors held 4,647 shares of Aehr Test Systems worth $172K as of Q1 2026.
  • RiverPark Advisors bought 1,249 Aehr Test Systems shares in Q1 2026, an estimated $40K.
  • Aehr Test Systems made up 0.06% of RiverPark Advisors's portfolio in Q1 2026, its #93 holding.
  • RiverPark Advisors first reported a position in Aehr Test Systems in Q3 2023 and has held it in 6 quarters since.
  • 191 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2026.

Based on RiverPark Advisors's 13F filing for Q1 2026, filed 14 May 2026.